Adalimumab ameliorates memory impairments and neuroinflammation in chronic cerebral hypoperfusion rats

Vascular dementia (VaD) is the second most common type of dementia worldwide. Although there are five FDA-approved drugs for the treatment of Alzheimer’s disease (AD), none of them have been applied to treat VaD. Adalimumab is a TNF-α inhibitor that is used for the treatment of autoimmune diseases s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Aging (Albany NY)
Autors principals: Xu, Jing-Jing, Guo, Si, Xue, Rui, Xiao, Lin, Kou, Jun-Na, Liu, Yu-Qiong, Han, Jun-Ya, Fu, Jing-Jie, Wei, Na
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals 2021
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8202885/
https://ncbi.nlm.nih.gov/pubmed/34030135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.203009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars